WilmerHale represented National Securities Clearing Corporation on the transaction. National Securities Clearing Corporation, a wholly-owned subsidiary of The Depository Trust & Clearing Corporation, has announced a private...
You must be a Standard 1 Year member to access this content.
WilmerHale represented State Street Corporation on the deal. State Street Corporation, an American financial services and bank, has announced a public offering of $1 billion aggregate principal amount of Fixed-to-Floating...
You must be a Standard 1 Year member to access this content.
WilmerHale advised Gilead Sciences on the deal. Gilead Sciences obtained a landmark victory on May 9, 2023 when a federal jury sided with the pharmaceutical company against the...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Datanomix on the deal. Datanomix, a leading production intelligence platform for precision manufacturers, recently announced that it secured $12...
You must be a Standard 1 Year member to access this content.
WilmerHale represented McCormick & Company on the deal. McCormick & Company, Incorporated, a manufacturer, marketer and distributor of spices, herbs, seasoning mixes, condiments and other flavorful...
You must be a Standard 1 Year member to access this content.
Latham & Watkins served as legal advisor to Basalt in the transaction, while Wilmer Cutler served as legal advisor to SDC Capital Partners. Basalt Infrastructure Partners...
You must be a Standard 1 Year member to access this content.
CMS Carey & Allende and Wilmer Cutler Pickering Hale and Dorr advised Toku, while Carey & Co. and Gunderson Dettmer advised F-Prime on the transaction. Toku closed...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Infinity Pharmaceuticals on the deal, while Morgan Lewis represented MEI Pharma Inc. Infinity Pharmaceuticals and MEI Pharma announced that...
You must be a Standard 1 Year member to access this content.
WilmerHale represented Volastra Therapeutics on the deal. Volastra Therapeutics, a clinical stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), closed its $60 million Series...
You must be a Standard 1 Year member to access this content.
WilmerHale advised Dalia on the deal. Dalia, a recruitment marketing automation platform, announced the completion of its Series A financing round led by Lewis & Clark...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised SecZetta on the deal. SailPoint Technologies, Inc., a leader in enterprise identity security, announced that it acquired firm client...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised TMX Group on the deal. FTMX Group Limited (TMX Group) announced that it has made a strategic investment in...
You must be a Standard 1 Year member to access this content.
